Pharmacokinetic and pharmacodynamic characterization of a novel formulation containing co-formulated interferons alpha-2b and gamma in healthy male volunteers

BACKGROUND: More potent antitumor activity is desired in Interferon (IFN)-treated cancer patients. This could be achieved by combining IFN alpha and IFN gamma. The aim of this work was to characterize the pharmacokinetics and pharmacodynamics of a novel formulation containing a co-formulated combina...

Descripción completa

Detalles Bibliográficos
Autores principales: García-García, Idrian, Hernández-González, Ignacio, Díaz-Machado, Alina, González-Delgado, Carlos A., Pérez-Rodríguez, Sonia, García-Vega, Yanelda, Campos-Mojena, Rosario, Tuero-Iglesias, Ángela D., Valenzuela-Silva, Carmen M., Cruz-Ramírez, Alieski, Martín-Trujillo, Alis, Santana-Milián, Héctor, López-Saura, Pedro A., Bello-Rivero, Iraldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142133/
https://www.ncbi.nlm.nih.gov/pubmed/27923408
http://dx.doi.org/10.1186/s40360-016-0103-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142133/
https://www.ncbi.nlm.nih.gov/pubmed/27923408
http://dx.doi.org/10.1186/s40360-016-0103-8

Ejemplares similares